Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

China · Delayed Price · Currency is CNY

41.62

-1.24 (-2.89%)

At close: May 21, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pelvic Floor Rehabilitation	160.01M	-				-	-	-
Reproductive Rehabilitation	127.11M	-				-	-	-
Sports Rehabilitation	8.76M	-				-	-	-
Other Products	1.64M	-				8.94M	978.19K	-
Other Products Growth	-	-				813.94%	-	-
Consumables and Accessories	122.31M	-				82.16M	75.89M	-
Consumables and Accessories Growth	-	-				8.26%	-	-
Pelvic Floor and Postpartum Rehabilitation Equipment	-	-				243.25M	176.98M	-
Pelvic Floor and Postpartum Rehabilitation Equipment Growth	-	-				37.44%	-	-
Diagnostic Kits / Equipment	-	-				-	-	143.44M
Total	419.82M	-				334.35M	253.84M	143.44M
Total Growth	-	-				31.71%	76.97%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	417.33M	-				336.52M	255.67M	143.44M
China Growth	-	-				31.62%	78.24%	-
Overseas	2.49M	-				-	-	-
Total	419.82M	-				336.52M	255.67M	143.44M
Total Growth	-	-				31.62%	78.24%	-

Source: S&P Global Market Intelligence.